State dependent dissociation of HERG channel inhibitors

D Stork1, E N Timin, S Berjukow

  • 1Department of Pharmacology and Toxicology, University of Vienna, Althanstrasse 14, Vienna 1090, Austria.

Insights

Drug block of HERG channels, crucial for cardiac rhythm, varies with cell pulsing rate. Some drugs show frequency-dependent block, while others appear trapped, impacting QT interval risk.

Area of Science:

  • Pharmacology
  • Cardiology
  • Molecular Biology

Background:

  • Inhibition of the human ether-à-go-go-related gene (hERG) channel prolongs the QT interval, increasing the risk of fatal torsades de pointes arrhythmias.
  • Many hERG channel blockers exhibit increased potency at higher stimulation frequencies, a phenomenon known as frequency-dependent block.
  • This frequency dependence can complicate the accurate assessment of drug-induced hERG channel block and associated cardiac risks.

Purpose of the Study:

  • To systematically compare the kinetics of hERG channel inhibition and recovery from block by eight different drug compounds.
  • To investigate the influence of varying stimulation frequencies on the IC(50) values of hERG channel blockers.
  • To elucidate the mechanisms underlying frequency-dependent block and drug dissociation from hERG channels.

Main Methods:

  • Heterologous expression of hERG channels in Xenopus oocytes.
  • Measurement of hERG channel currents using the two-electrode voltage clamp technique.
  • Systematic assessment of drug block and recovery kinetics at different stimulation frequencies.

Main Results:

  • Four compounds (amiodarone, cisapride, droperidol, haloperidol) demonstrated frequency-dependent block (Group 1).
  • Four compounds (bepridil, domperidone, E-4031, terfenadine) showed similar block across frequencies, with limited recovery from block (Group 2).
  • Frequent pulsing enhanced the washout of Group 2 compounds, and a specific mutation (D540K) facilitated recovery from block by these agents.

Conclusions:

  • Drug dissociation rates from open and closed hERG channels differ, leading to 'use-dependent' block.
  • Group 1 drugs dissociate from both open and resting states, while Group 2 drugs appear to dissociate primarily from the open state, leading to 'trapped' kinetics.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...